U.S. Markets closed

Intellipharmaceutics reports 1Q loss

TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCI) on Tuesday reported a loss of $2 million in its fiscal first quarter.

The Toronto-based company said it had a loss of 7 cents per share.

The extended-release drug developer posted revenue of $1.2 million in the period.

In the final minutes of trading on Tuesday, the company's shares hit $2.05. A year ago, they were trading at $2.18.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPCI at https://www.zacks.com/ap/IPCI


Keywords: Intellipharmaceutics International, Earnings Report